Carmat Financials
| ALCAR Stock | EUR 1.09 0.01 0.91% |
Carmat |
Understanding current and past Carmat Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Carmat's financial statements are interrelated, with each one affecting the others. For example, an increase in Carmat's assets may result in an increase in income on the income statement.
Carmat Stock Summary
Carmat competes with Gensight Biologics, Innate Pharma, Poxel SA, and Nanobiotix. Carmat SA designs and develops total artificial heart for people suffering from end-stage biventricular heart failure in France and internationally. The company was founded in 2008 and is based in Vlizy-Villacoublay, France. CARMAT operates under Medical Instruments Supplies classification in France and is traded on Paris Stock Exchange. It employs 81 people.| Instrument | France Stock View All |
| Exchange | Euronext Paris |
| ISIN | FR0010907956 |
| Business Address | 36, avenue de |
| Sector | Health Care Equipment & Supplies |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | www.carmatsa.com |
| Phone | 33 1 39 45 64 50 |
| Currency | EUR - Euro |
You should never invest in Carmat without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Carmat Stock, because this is throwing your money away. Analyzing the key information contained in Carmat's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Carmat Key Financial Ratios
Carmat's financial ratios allow both analysts and investors to convert raw data from Carmat's financial statements into concise, actionable information that can be used to evaluate the performance of Carmat over time and compare it to other companies across industries.| Return On Equity | -2.54 | |||
| Return On Asset | -0.39 | |||
| Target Price | 28.6 | |||
| Number Of Employees | 171 | |||
| Beta | 0.94 |
Carmat Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Carmat's current stock value. Our valuation model uses many indicators to compare Carmat value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Carmat competition to find correlations between indicators driving Carmat's intrinsic value. More Info.Carmat is rated fourth in return on equity category among its peers. It also is rated fourth in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Carmat's earnings, one of the primary drivers of an investment's value.Carmat Systematic Risk
Carmat's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Carmat volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Beta measures systematic risk based on how returns on Carmat correlated with the market. If Beta is less than 0 Carmat generally moves in the opposite direction as compared to the market. If Carmat Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Carmat is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Carmat is generally in the same direction as the market. If Beta > 1 Carmat moves generally in the same direction as, but more than the movement of the benchmark.
Carmat December 14, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Carmat help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Carmat. We use our internally-developed statistical techniques to arrive at the intrinsic value of Carmat based on widely used predictive technical indicators. In general, we focus on analyzing Carmat Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Carmat's daily price indicators and compare them against related drivers.
| Information Ratio | (0.18) | |||
| Maximum Drawdown | 27.84 | |||
| Value At Risk | (6.67) | |||
| Potential Upside | 7.53 |
Additional Tools for Carmat Stock Analysis
When running Carmat's price analysis, check to measure Carmat's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Carmat is operating at the current time. Most of Carmat's value examination focuses on studying past and present price action to predict the probability of Carmat's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Carmat's price. Additionally, you may evaluate how the addition of Carmat to your portfolios can decrease your overall portfolio volatility.